H.C. Wainwright Reiterates Aptose Biosciences (APTO) at Buy with $12 PT, Sees HM43239 as Key Potential Value Driver
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $12.00 price target on Aptose Biosciences (NASDAQ: APTO), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
